<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CAR-T Terapisi &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/car-t-terapisi/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 25 Nov 2025 00:53:13 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>CAR-T Terapisi &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>C-Met Mutation and CAR-T Strategy for Ovarian Cancer</title>
		<link>https://bioengineer.org/c-met-mutation-and-car-t-strategy-for-ovarian-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 25 Nov 2025 00:53:04 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[CAR-T Terapisi]]></category>
		<category><![CDATA[Hedefe Yönelik Tedavi** * **c-Met rs368750834:** Makalenin odak noktası olan spesifik gen]]></category>
		<category><![CDATA[İşte içeriğe uygun 5 adet Türkçe etiket]]></category>
		<category><![CDATA[Seröz Over Karsinomu]]></category>
		<category><![CDATA[Tümör mikroçevresi]]></category>
		<category><![CDATA[virgülle ayrılmış halde: **c-Met rs368750834]]></category>
		<guid isPermaLink="false">https://bioengineer.org/c-met-mutation-and-car-t-strategy-for-ovarian-cancer/</guid>

					<description><![CDATA[In the ever-evolving landscape of cancer research, new breakthroughs frequently emerge, offering hope and insights into previously challenging conditions. One such advancement emerges from a recent study that delves into the complexities of serous ovarian carcinoma, investigating the crucial c-Met rs368750834 mutation and its implications for innovative treatment strategies. Conducted by a team of prominent [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">300811</post-id>	</item>
	</channel>
</rss>
